Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248156 · ClinicalTrials.gov registry record
The Maintenance of Human Atrial Fibrillation
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 5
- Enrollment target
NCT01248156 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 5 participants.
The verdict
NCT01248156 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Atrial fibrillation (AF) is the most prevalent heart rhythm disorder in the United States, affecting 2.5 million individuals in whom it may cause stroke, palpitations, heart failure, and even death. Unfortunately, therapy for AF is limited. Anti-arrhythmic or rate-controlling drugs are poorly tolerated, with frequent side effects and do not reduce stroke risk. Ablation is an emerging, minimally invasive therapy that has attracted considerable attention because it may eliminate AF. Unfortunately, AF ablation is technically challenging, with a success of only 50-70% (versus \>90% for other arrhythmias) and serious risks. A major cause of these limitations is that the mechanisms for human AF are not known and thus ablation cannot be directed to them. As a result, AF ablation is empiric and results in extensive destruction of the atrium. This project will perform research to better understand AF and determine if abnormal activity in small regions or more widespread regions of the heart cause AF. By performing these studies in patients during clinical procedures, this project may lead to a paradigm shift in the understanding and treatment of AF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01248156
The ClinicalTrials.gov registry entry for NCT01248156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01248156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01248156 about?
NCT01248156 is a clinical study titled "The Maintenance of Human Atrial Fibrillation". Atrial fibrillation (AF) is the most prevalent heart rhythm disorder in the United States, affecting 2.5 million individuals in whom it may cause stroke, palpitations, heart failure, and even death. Unfortunately, therapy for AF is limited. Anti-arrhythmic or rate-controlling drugs are poorly tolera...
What is the current status of trial NCT01248156?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2010-12. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01248156?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.